Article
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
PLoS medicine - 1 Jan 2012
Lockman Shahin, Hughes Michael, Sawe Fred, Zheng Yu, McIntyre James, Chipato Tsungai, Asmelash Aida, Rassool Mohammed, Kimaiyo Sylvester, Shaffer Douglas, Hosseinipour Mina, Mohapi Lerato, Ssali Francis, Chibowa Margret, Amod Farida, Halvas Elias, Hogg Evelyn, Alston-Smith Beverly, Smith Laura, Schooley Robert, Mellors John, Currier Judith
Abstract excerpt
BACKGROUND: Nevirapine (NVP) is widely used in antiretroviral treatment (ART) of HIV-1 globally. The primary objective of the AA5208/OCTANE trial was to compare the efficacy of NVP-based versus lopinavir/ritonavir (LPV/r)-based initial ART. METHODS AND FINDINGS: In seven African countries (Botswana, Kenya, Malawi, South Africa, Uganda, Zambia, and Zimbabwe), 500 antiretroviral-naïve HIV-infected women with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
